min read

Employees are underutilizing your mental health resources – and that’s a good thing

Learn from a mental health expert on the impact of resource underutilization, opportunities, and solutions available for employees with mental health issues.

The prevalence of mental health conditions is rising – on average, 20% of a company’s employee population are suffering from a clinical mental health condition at any given time. Despite an increase in mental health concerns and an overall decrease in mental health stigma, only 10% of employees are using the services employers offer. So, if rates of mental health conditions show no indication of slowing down, and many employers have prioritized mental health resources as part of their benefits offerings – why are they so underutilized? Additionally, what would happen if more employees took advantage of these services? Spoiler: it would be problematic.

Dr. Marie Atallah, psychologist and Clinical Communications Lead at Big Health, helps us answer these pressing questions and breaks down what employers need to know about utilization and the evidence-based solutions available.

What leads to underutilization?

Cognitive behavioral therapy is the first line of treatment recommended for most mental health conditions and insomnia. However, according to Dr. Atallah, there are many barriers to accessing this type of care. While the mental health provider shortage is not a new issue, the problem gets intensified when it comes to finding therapists trained in the evidence-based treatments that are recommended. Additionally, individuals looking for care face other barriers  such as stigma, affordability, treatment-seeking behavior, cultural barriers, and time. “While virtual care has been able to reduce some of these barriers, the traditional model of care continues to be unable to meet demand,” says Dr. Atallah. Virtual therapy shows great promise for making therapy more accessible and convenient; however, it continues to be underutilized, does not adequately address the provider shortage, and cannot guarantee consistent and equitable evidence-based care is delivered.  

“Wait times are a major deterrent to seeking mental health care, especially to someone who is already reluctant to reach out for help,” says Dr. Atallah. “While efforts to increase mental health awareness have been effective, more people reaching out for care has the potential to further flood the already burdened mental health system.”

Risks and impacts of a therapist shortage

Traditional models of therapy, i.e., talk therapy, are only one model of mental health care available. And it’s important to understand that this model of care isn’t sustainable for meeting higher demands. Simply put, there aren’t enough trained mental health professionals available to care for the growing number of people in need. One study of psychiatrist’s availability across 3 major U.S. cities found that the average wait time for an initial appointment was 25 days. Given there is already a noticeable delay for care, any increase in demand could quickly escalate access issues – leaving many without any option. Delays in care can also increase the risk of catastrophic events occurring, especially from those that need more acute help.

So, what are the potential impacts and risks of this therapist shortage for organizations? According to Dr. Atallah, primary care providers have historically been the more accessible option to address mental health care needs. While there are some positive impacts of this – such as faster access to care, the ability to receive medications for symptoms, and a sense of support – there are also real risks. Primary care providers are not trained therapists that specialize in mental health care. They are primarily trained in administering medications which carry a side-effect risk profile that can be habit forming and not the preferred treatment method of many people looking for help.                                                                                                                                                                                                                                                                                                                                                                                        

Identifying a supplemental care model

It’s clear that there is a need for a more sustainable and scalable model of care to help avoid these risks and ensure faster access to evidence-based therapy – not to serve as a replacement for talk therapy for those with access, but as an aid to help meet demands when therapists are not available. Digital, evidence-based solutions are more scalable and consistent, which makes them better able to ensure that everyone has access to the gold-standard of care regardless of other social determinants of health.

Automated interventions such as Sleepio and Daylight show potential for addressing the inconsistencies that are present with human-delivered care. For example, research on Sleepio showed that effectiveness did not vary across ethnicity. On the contrary, there is a cultural and racial underrepresentation of mental health providers.

For employers looking to provide their workforce with timely and equitable mental health care without adding stress to the already overburdened system, digital-based solutions are the clear answer.

Visit online for more information on how digital-based solutions can improve employee utilization or read similar articles on our blog.

No items found.

Subscribe to blog

During the COVID-19 public health emergency, Sleepio and Daylight are being made available as treatments for insomnia disorder and generalized anxiety disorder (GAD), respectively, without a prescription. Sleepio and Daylight have not been cleared by the U.S. Food and Drug Administration (FDA) for the treatment of insomnia disorder and GAD, respectively.

1. Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125-133.2. Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., … & Spiegelhalder, K. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 26(6), 675-700.3. Wilson, S., Anderson, K., Baldwin, D., Dijk, D. J., Espie, A., Espie, C., … & Sharpley, A. (2019). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. Journal of Psychopharmacology, 33(8), 923-947.4. King’s Technology Evaluation Centre. (2017, November 9). Overview: Health app: SLEEPIO for adults with poor Sleep: Advice. NICE. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769-781.6. Carl, J. R., Miller, C. B., Henry, A. L., Davis, M. L., Stott, R., Smits, J. A., … & Espie, C. A. (2020). Efficacy of digital cognitive behavioral therapy for moderate‐to‐severe symptoms of generalized anxiety disorder: A randomized controlled trial. Depression and Anxiety, 37(12), 1168-1178.

DOC-3046 Effective 11/2023